Finance

Lists
ANUHPHR:NSE
Anuh Pharma Ltd
₹76.00
+0.37%
(+0.28) 1D
Aug 18, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ANUHPHR...
Open
₹75.72
High
₹76.83
Low
₹75.50
Mkt. cap
7.62B
Avg. vol.
0.00
Volume
39.87K
Dividend
1.97%
Quarterly dividend
₹0.37
Ex-dividend date
Aug 5, 2026
P/E ratio
17.25
52-wk high
₹94.89
52-wk low
₹67.00
EPS
₹4.41
No. of employees
323
Open
₹75.72
High
₹76.83
Low
₹75.50
Mkt. cap
7.62B
Avg. vol.
0.00
Volume
39.87K
Dividend
1.97%
Quarterly dividend
₹0.37
Ex-dividend date
Aug 5, 2026
P/E ratio
17.25
52-wk high
₹94.89
52-wk low
₹67.00
EPS
₹4.41
No. of employees
323
About Anuh Pharma Ltd
CEO-
Employees323
Founded1960
Headquarters-
SectorPharmaceutical industry
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.94B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.86B
1.97B
2.02B
1.94B
Cost of goods sold
1.45B
1.51B
1.60B
1.48B
Cost of revenue
1.45B
1.51B
1.60B
1.48B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67.46M
69.11M
80.08M
73.52M
Operating expense
323.32M
321.02M
161.01M
316.47M
Total operating expenses
1.77B
1.83B
1.76B
1.80B
Operating income
90.18M
137.98M
258.68M
138.55M
Other non operating income
9.78M
41.10M
-84.72M
30.77M
EBT including unusual items
99.21M
178.28M
155.20M
169.28M
EBT excluding unusual items
99.21M
178.28M
118.28M
169.28M
Income tax expense
23.08M
43.77M
38.38M
55.03M
Effective tax rate
23.27%
24.55%
24.73%
32.51%
Other operating expenses
227.24M
221.89M
52.55M
218.62M
Net income
76.12M
134.51M
116.81M
114.25M
Net profit margin
4.10%
6.82%
5.78%
5.89%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6.60M
-
Interest expense
-756.00K
-796.00K
-1.06M
-35.00K
Net interest expenses
-756.00K
-796.00K
5.54M
-35.00K
Depreciation and amortization charges
28.62M
30.02M
28.38M
24.33M
EBITDA
117.06M
158.54M
285.83M
165.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps